ON AN EARLY December morning in 2004, a panel of advisors to the Food & Drug Administration gathered at a hotel outside of Washington, D.C., to review some data. Pharmaceutical giant Procter & Gamble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results